{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T08:11:40Z","timestamp":1779351100643,"version":"3.51.4"},"reference-count":34,"publisher":"e-Century Publishing Corporation","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Transl Res"],"DOI":"10.62347\/niho7276","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T03:53:17Z","timestamp":1777348397000},"page":"2896-2907","source":"Crossref","is-referenced-by-count":0,"title":["Correlation of serum MAp44 protein concentration with degree of myocardial injury and 30-day prognosis in patients with acute myocardial infarction"],"prefix":"10.62347","volume":"18","author":[{"given":"Chen-Yan","family":"Song","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"48694","published-online":{"date-parts":[[2026]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"8504","DOI":"10.3390\/ijms25158504","article-title":"Acute hyperglycemia-induced injury in myocardial infarction","volume":"25","author":"Pepe","year":"2024","unstructured":"Pepe M, Addabbo F, Cecere A, Tritto R, Napoli G, Nestola PL, Cirillo P, Biondi-Zoccai G, Giordano S and Ciccone MM. Acute hyperglycemia-induced injury in myocardial infarction. Int J Mol Sci 2024; 25: 8504.","journal-title":"Int J Mol Sci"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1093\/eurheartj\/ehad486","article-title":"Inflammation in acute myocardial infarction: the good, the bad and the ugly","volume":"45","author":"MA","year":"2024","unstructured":"Matter MA, Paneni F, Libby P, Frantz S, Stähli BE, Templin C, Mengozzi A, Wang YJ, Kündig TM, Räber L, Ruschitzka F and Matter CM. Inflammation in acute myocardial infarction: the good, the bad and the ugly. Eur Heart J 2024; 45: 89-103.","journal-title":"Eur Heart J"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1093\/eurjpc\/zwab213","article-title":"Burden of ischemic heart disease and its attributable risk factors in 204 countries and territories, 1990-2019","volume":"29","author":"Safiri","year":"2022","unstructured":"Safiri S, Karamzad N, Singh K, Carson-Chahhoud K, Adams C, Nejadghaderi SA, Almasi-Hashiani A, Sullman MJM, Mansournia MA, Bragazzi NL, Kaufman JS, Collins GS and Kolahi AA. Burden of ischemic heart disease and its attributable risk factors in 204 countries and territories, 1990-2019. Eur J Prev Cardiol 2022; 29: 420-431.","journal-title":"Eur J Prev Cardiol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"518","DOI":"10.46234\/ccdcw2022.026","article-title":"Case fatality rate of patients with acute myocardial infarction in 253 chest pain centers - China, 2019-2020","volume":"4","author":"Long","year":"2022","unstructured":"Long Z, Liu W, Zhao Z, Tong S, Wang L, Zhou M, Xiang D, Chen Y, Wang J, Cheng X, Li B, Li L, Li W, Shi B, Shi H, Yin P, Huang K and Huo Y. Case fatality rate of patients with acute myocardial infarction in 253 chest pain centers - China, 2019-2020. China CDC Wkly 2022; 4: 518-521.","journal-title":"China CDC Wkly"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.jjcc.2022.07.003","article-title":"Treatment strategies of acute myocardial infarction: updates on revascularization, pharmacological therapy, and beyond","volume":"81","author":"Saito","year":"2023","unstructured":"Saito Y, Oyama K, Tsujita K, Yasuda S and Kobayashi Y. Treatment strategies of acute myocardial infarction: updates on revascularization, pharmacological therapy, and beyond. J Cardiol 2023; 81: 168-178.","journal-title":"J Cardiol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s12872-022-02631-8","article-title":"Short-term\/long-term prognosis with or without beta-blockers in patients without heart failure and with preserved ejection fraction after acute myocardial infarction: a multicenter retrospective cohort study","volume":"22","author":"Wen","year":"2022","unstructured":"Wen XS, Luo R, Liu J, Duan Q, Qin S, Xiao J and Zhang DY. Short-term\/long-term prognosis with or without beta-blockers in patients without heart failure and with preserved ejection fraction after acute myocardial infarction: a multicenter retrospective cohort study. BMC Cardiovasc Disord 2022; 22: 193.","journal-title":"BMC Cardiovasc Disord"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1093\/ehjacc\/zuae014","article-title":"Periprocedural myocardial infarction and injury","volume":"13","author":"Spagnolo","year":"2024","unstructured":"Spagnolo M, Occhipinti G, Laudani C, Greco A and Capodanno D. Periprocedural myocardial infarction and injury. Eur Heart J Acute Cardiovasc Care 2024; 13: 433-445.","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1093\/cei\/uxad113","article-title":"Plasma levels of mannan-binding lectin-associated serine proteases are increased in type 1 diabetes patients with insulin resistance","volume":"215","author":"Kietsiriroje","year":"2024","unstructured":"Kietsiriroje N, Scott GE, Ajjan RA, Brôz J, Schroeder V and Campbell MD. Plasma levels of mannan-binding lectin-associated serine proteases are increased in type 1 diabetes patients with insulin resistance. Clin Exp Immunol 2024; 215: 58-64.","journal-title":"Clin Exp Immunol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1093\/cvr\/cvae075","article-title":"Serine protease inhibitor, SerpinA3n, regulates cardiac remodelling after myocardial infarction","volume":"120","author":"Sun","year":"2024","unstructured":"Sun Q, Chen W, Wu R, Tao B, Wang P, Sun B, Alvarez JF, Ma F, Galindo DC, Maroney SP, Saviola AJ, Hansen KC, Li S and Deb A. Serine protease inhibitor, SerpinA3n, regulates cardiac remodelling after myocardial infarction. Cardiovasc Res 2024; 120: 943-953.","journal-title":"Cardiovasc Res"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"9181","DOI":"10.3390\/ijms24119181","article-title":"Cooperation of complement MASP-1 with other proinflammatory factors to enhance the activation of endothelial cells","volume":"24","author":"N&#xE9","year":"2023","unstructured":"Németh Z, Debreczeni ML, Kajdácsi E, Dobó J, Gál P and Cervenak L. Cooperation of complement MASP-1 with other proinflammatory factors to enhance the activation of endothelial cells. Int J Mol Sci 2023; 24: 9181.","journal-title":"Int J Mol Sci"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1615\/CritRevImmunol.2025057896","article-title":"MAp44: emerging insights into its role in disease pathogenesis and association with various diseases","volume":"45","author":"Pamei","year":"2025","unstructured":"Pamei YG, Swekcha, Sharma N and Toor D. MAp44: emerging insights into its role in disease pathogenesis and association with various diseases. Crit Rev Immunol 2025; 45: 57-70.","journal-title":"Crit Rev Immunol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"606407","DOI":"10.3389\/fcell.2020.606407","article-title":"The role of complement in myocardial infarction reperfusion injury: an underappreciated therapeutic target","volume":"8","author":"Vogel","year":"2020","unstructured":"Vogel CW. The role of complement in myocardial infarction reperfusion injury: an underappreciated therapeutic target. Front Cell Dev Biol 2020; 8: 606407.","journal-title":"Front Cell Dev Biol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.3390\/antiox12111944","article-title":"Inflammation in myocardial ischemia\/reperfusion injury: underlying mechanisms and therapeutic potential","volume":"12","author":"Francisco","year":"2023","unstructured":"Francisco J and Del Re DP. Inflammation in myocardial ischemia\/reperfusion injury: underlying mechanisms and therapeutic potential. Antioxidants (Basel) 2023; 12: 1944.","journal-title":"Antioxidants (Basel)"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1186\/s12967-024-05178-8","article-title":"Comprehensive mendelian randomization analysis of plasma proteomics to identify new therapeutic targets for the treatment of coronary heart disease and myocardial infarction","volume":"22","author":"Sun","year":"2024","unstructured":"Sun Z, Yun Z, Lin J, Sun X, Wang Q, Duan J, Li C, Zhang X, Xu S, Wang Z, Xiong X and Yao K. Comprehensive mendelian randomization analysis of plasma proteomics to identify new therapeutic targets for the treatment of coronary heart disease and myocardial infarction. J Transl Med 2024; 22: 404.","journal-title":"J Transl Med"},{"key":"ref14","unstructured":"Cardiovascular Disease Branch of Chinese Medical Association, Editorial Committee of Chinese Journal of Cardiovascular Diseases and Editorial Committee of Chinese Journal of Circulation. Diagnosis and treatment guidelines for Acute Myocardial infarction [J]. Chinese Journal of Cardiovascular Diseases 2001; 29: 710-725."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1161\/01.CIR.93.5.879","article-title":"TIMI frame count: a quantitative method of assessing coronary artery flow","volume":"93","author":"Gibson","year":"1996","unstructured":"Gibson CM, Cannon CP, Daley WL, Dodge JT Jr, Alexander B Jr, Marble SJ, McCabe CH, Raymond L, Fortin T, Poole WK and Braunwald E. TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation 1996; 93: 879-88.","journal-title":"Circulation"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1016\/j.amjmed.2022.08.017","article-title":"Mechanical complications of myocardial infarction","volume":"135","author":"Murphy","year":"2022","unstructured":"Murphy A and Goldberg S. Mechanical complications of myocardial infarction. Am J Med 2022; 135: 1401-1409.","journal-title":"Am J Med"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"152349","DOI":"10.1016\/j.imbio.2023.152349","article-title":"l-ficolin-MASP arm of the complement system in schizophrenia","volume":"228","author":"Mayilyan","year":"2023","unstructured":"Mayilyan KR, Krarup A, Soghoyan AF, Jensenius JC and Sim RB. l-ficolin-MASP arm of the complement system in schizophrenia. Immunobiology 2023; 228: 152349.","journal-title":"Immunobiology"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"14882","DOI":"10.1038\/s41598-024-64479-6","article-title":"Detrimental interactions of hypoxia and complement MASP-1 in endothelial cells as a model for atherosclerosis-related diseases","volume":"14","author":"Demeter","year":"2024","unstructured":"Demeter F, Németh Z, Kajdácsi E, Bihari G, Dobó J, Gál P and Cervenak L. Detrimental interactions of hypoxia and complement MASP-1 in endothelial cells as a model for atherosclerosis-related diseases. Sci Rep 2024; 14: 14882.","journal-title":"Sci Rep"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"131193","DOI":"10.1016\/j.ijcard.2023.131193","article-title":"Mannose binding lectin-associated serine protease-1 is a novel contributor to myocardial ischemia\/reperfusion injury","volume":"389","author":"Zhang","year":"2023","unstructured":"Zhang S, Yang L, Guo S, Hu F, Cheng D, Sun J, Li Y, Xu J and Sang H. Mannose binding lectin-associated serine protease-1 is a novel contributor to myocardial ischemia\/reperfusion injury. Int J Cardiol 2023; 389: 131193.","journal-title":"Int J Cardiol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1161\/ATVBAHA.115.306552","article-title":"Distinct longitudinal associations of MBL, MASP-1, MASP-2, MASP-3, and MAp44 with endothelial dysfunction and intima-media thickness: the cohort on diabetes and atherosclerosis maastricht (CODAM) study","volume":"36","author":"Hertle","year":"2016","unstructured":"Hertle E, Arts IC, van der Kallen CJ, Feskens EJ, Schalkwijk CG, Hoffmann-Petersen IT, Thiel S, Stehouwer CD and van Greevenbroek MM. Distinct longitudinal associations of MBL, MASP-1, MASP-2, MASP-3, and MAp44 with endothelial dysfunction and intima-media thickness: the cohort on diabetes and atherosclerosis maastricht (CODAM) study. Arterioscler Thromb Vasc Biol 2016; 36: 1278-85.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.3390\/ijms25031566","article-title":"The lectin pathway of the complement system-activation, regulation, disease connections and interplay with other (Proteolytic) systems","volume":"25","author":"Dob&#xF3","year":"2024","unstructured":"Dobó J, Kocsis A, Farkas B, Demeter F, Cervenak L and Gál P. The lectin pathway of the complement system-activation, regulation, disease connections and interplay with other (Proteolytic) systems. Int J Mol Sci 2024; 25: 1566.","journal-title":"Int J Mol Sci"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1561850","DOI":"10.3389\/fimmu.2025.1561850","article-title":"Corrigendum: distinction of early complement classical and lectin pathway activation via quantification of C1s\/C1-INH and MASP-1\/C1-INH complexes using novel ELISAs","volume":"16","author":"Hurler","year":"2025","unstructured":"Hurler L, Toonen EJM, Kajdácsi E, van Bree B, Brandwijk RJMGE, de Bruin W, Lyons PA, Bergamaschi L; Cambridge Institute of Therapeutic Immunology Infectious Disease-National Institute of Health Research (CITIID-NIHR) COVID BioResource Collaboration, Sinkovits G, Cervenak L, Würzner R and Prohászka Z. Corrigendum: distinction of early complement classical and lectin pathway activation via quantification of C1s\/C1-INH and MASP-1\/C1-INH complexes using novel ELISAs. Front Immunol 2025; 16: 1561850.","journal-title":"Front Immunol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1320811","DOI":"10.3389\/fmed.2024.1320811","article-title":"Systematic analysis of MASP-1 serves as a novel immune-related biomarker in sepsis and trauma followed by preliminary experimental validation","volume":"11","author":"Xian","year":"2024","unstructured":"Xian L, Cheng S, Chen W, Zhong C, Hu Z and Deng X. Systematic analysis of MASP-1 serves as a novel immune-related biomarker in sepsis and trauma followed by preliminary experimental validation. Front Med (Lausanne) 2024; 11: 1320811.","journal-title":"Front Med (Lausanne)"},{"key":"ref24","unstructured":"Liu F, Liu XJ, He YP, Liu GB, Lan T and Ye JS. Clinical value of GRACE score combined with DFR in predicting short-term prognosis of patients undergoing early PCI after thrombolysis for acute myocardial infarction. Eur Rev Med Pharmacol Sci 2023; 27: 4038-4045."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"429","DOI":"10.4149\/bll_2024_66","article-title":"Five-year prognosis of patients with acute myocardial infarction and out-of-hospital cardiac arrest","volume":"125","author":"Alusik","year":"2024","unstructured":"Alusik D, Corba A, Kmec J, Kubica I, Romanova L, Gal P and Studencan M. Five-year prognosis of patients with acute myocardial infarction and out-of-hospital cardiac arrest. Bratisl Lek Listy 2024; 125: 429-434.","journal-title":"Bratisl Lek Listy"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"2220420","DOI":"10.1080\/0886022X.2023.2220420","article-title":"The use of high-sensitivity cardiac troponin T and creatinine kinase-MB as a prognostic markers in patients with acute myocardial infarction and chronic kidney disease","volume":"45","author":"Chen","year":"2023","unstructured":"Chen Y, Zhou X, Chen Z, Xia J, Guan F, Li Y, Li Y, Chen Y, Zhao Y, Qiu H, Liang J and Tang L. The use of high-sensitivity cardiac troponin T and creatinine kinase-MB as a prognostic markers in patients with acute myocardial infarction and chronic kidney disease. Ren Fail 2023; 45: 2220420.","journal-title":"Ren Fail"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s00392-024-02536-w","article-title":"Correlation of greyzone fibrosis compared to troponin T and late gadolinium enhancement with survival and ejection fraction in patients after acute myocardial infarction","volume":"114","author":"Schmitt","year":"2025","unstructured":"Schmitt R, Staats C, Kaier K, Ahlgrim C, Hein M, Brado J, Steinhoff P, Billig H, Soschynski M, Krauss T, Schlett CL, Westermann D, Neumann FJ, Ruile P and Breitbart P. Correlation of greyzone fibrosis compared to troponin T and late gadolinium enhancement with survival and ejection fraction in patients after acute myocardial infarction. Clin Res Cardiol 2025; 114: 749-759.","journal-title":"Clin Res Cardiol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1297352","DOI":"10.3389\/fimmu.2023.1297352","article-title":"Development and characterization of narsoplimab, a selective MASP-2 inhibitor, for the treatment of lectin-pathway-mediated disorders","volume":"14","author":"Dudler","year":"2023","unstructured":"Dudler T, Yaseen S and Cummings WJ. Development and characterization of narsoplimab, a selective MASP-2 inhibitor, for the treatment of lectin-pathway-mediated disorders. Front Immunol 2023; 14: 1297352.","journal-title":"Front Immunol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"574457","DOI":"10.3389\/fimmu.2020.574457","article-title":"Hepatitis B virus infection among leprosy patients: a case for polymorphisms compromising activation of the lectin pathway and complement receptors","volume":"11","author":"ABW","year":"2021","unstructured":"Boldt ABW, Oliveira-Toré CF, Kretzschmar GC, Weinschutz Mendes H, Stinghen ST, Andrade FA, Bumiller-Bini V, Gonçalves LB, Braga ACM, Stahlke EVRS, Velavan TP, Thiel S and de Messias-Reason IJT. Hepatitis B virus infection among leprosy patients: a case for polymorphisms compromising activation of the lectin pathway and complement receptors. Front Immunol 2021; 11: 574457.","journal-title":"Front Immunol"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Mistegaard CE, Jensen L, Christiansen M, Bjerre M, Jensen JMB and Thiel S. Low levels of the innate immune system proteins MASP-2 and MAp44 in patients with common variable immunodeficiency. Scand J Immunol 2022; 96: e13196.","DOI":"10.1111\/sji.13196"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"Frederiksen K, Krag AE, Larsen JB, Kiil BJ, Thiel S and Hvas AM. Remote ischemic preconditioning does not influence lectin pathway protein levels in head and neck cancer patients undergoing surgery. PLoS One 2020; 15: e0230411.","DOI":"10.1371\/journal.pone.0230411"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"2930","DOI":"10.1038\/s41598-019-39742-w","article-title":"Factors involved in initiation and regulation of complement lectin pathway influence postoperative outcome after pediatric cardiac surgery involving cardiopulmonary bypass","volume":"9","author":"Michalski","year":"2019","unstructured":"Michalski M, Pągowska-Klimek I, Thiel S, Świerzko AS, Hansen AG, Jensenius JC and Cedzyński M. Factors involved in initiation and regulation of complement lectin pathway influence postoperative outcome after pediatric cardiac surgery involving cardiopulmonary bypass. Sci Rep 2019; 9: 2930.","journal-title":"Sci Rep"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/cei.12093","article-title":"Plasma levels of mannan-binding lectin (MBL)-associated serine proteases (MASPs) and MBL-associated protein in cardio- and cerebrovascular diseases","volume":"173","author":"Frauenknecht","year":"2013","unstructured":"Frauenknecht V, Thiel S, Storm L, Meier N, Arnold M, Schmid JP, Saner H and Schroeder V. Plasma levels of mannan-binding lectin (MBL)-associated serine proteases (MASPs) and MBL-associated protein in cardio- and cerebrovascular diseases. Clin Exp Immunol 2013; 173: 112-20.","journal-title":"Clin Exp Immunol"}],"container-title":["American Journal of Translational Research"],"original-title":[],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T07:56:57Z","timestamp":1779350217000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajtr\/18\/4\/ajtr0169563.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":34,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.62347\/niho7276","relation":{},"ISSN":["1943-8141"],"issn-type":[{"value":"1943-8141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]}}}